Heron Therapeutics Inc (NASDAQ:HRTX)

30.20
Delayed Data
As of Jul 02
 -0.65 / -2.11%
Today’s Change
6.51
Today|||52-Week Range
34.03
+200.20%
Year-to-Date

Today’s Trading

Previous close30.85
Today’s open30.84
Day’s range30.03 - 30.84
Volume267,331
Average volume (3 months)1,443,965
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+0.81%
Earnings growth (next 5 years)+44.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.44

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...-0.31-0.99%
ARNAArena Pharmaceutical...-0.03-0.67%
PDLIPDL BioPharma Inc-0.28-4.37%
MGNXMacroGenics Inc+0.09+0.26%
Data as of 3:59pm ET, 07/02/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers